878207-82-0 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Dibromo-5-fluoropyridine is utilized as a key intermediate in the synthesis of a range of pharmaceutical products, including antibacterial and antifungal agents. Its role in these syntheses is crucial for developing new drugs that combat resistant strains of bacteria and fungi, thereby contributing to the advancement of modern medicine.
Used in Agrochemical Industry:
In the agrochemical sector, 2,3-Dibromo-5-fluoropyridine serves as a vital component in the creation of pesticides and other agricultural chemicals. Its application helps in enhancing crop protection and yield by combating pests and diseases effectively.
Used as a Reagent in Organic Synthesis:
2,3-Dibromo-5-fluoropyridine is also employed as a reagent in organic synthesis, particularly for the production of compounds with significant biological activity. Its ability to undergo multiple chemical reactions facilitates the creation of a broad spectrum of molecules with potential applications in various fields.
Overall, 2,3-Dibromo-5-fluoropyridine's applications cut across different industries, highlighting its importance and versatility in chemical and biological research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 878207-82-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,2,0 and 7 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 878207-82:
(8*8)+(7*7)+(6*8)+(5*2)+(4*0)+(3*7)+(2*8)+(1*2)=210
210 % 10 = 0
So 878207-82-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H2Br2FN/c6-4-1-3(8)2-9-5(4)7/h1-2H
878207-82-0Relevant academic research and scientific papers
NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS
-
Page/Page column 154-155, (2011/12/02)
Unsaturated nitrogen heterocyclic compounds of formula (I): (I), as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
ADAMANTYL DERIVATES AS P2X7 RECEPTOR ANTAGONISTS
-
Page/Page column 147, (2010/10/20)
The invention provides compounds of formula (I) pharmaceutically acceptable salt or solvate thereof, in which R1, A1, m and A are as defined in the specification; a process for their preparation; pharmaceutical compositions containin
